Immediate Impact
20 hit
Citing Papers
Cancer treatment and survivorship statistics, 2025
2025 Hit
Therapeutic landscape and future direction of metastatic colorectal cancer
2023 Hit
Works of Anthony Magliocco being referenced
A randomized phase II study of trastuzumab and pertuzumab (TP) compared to cetuximab and irinotecan (CETIRI) in advanced/metastatic colorectal cancer (mCRC) with HER2 amplification: S1613.
2018
International harmonization of diagnostic criteria for HER2-amplified metastatic colorectal cancer and application of targeted next-generation sequencing panel as a diagnostic method.
2018